Clincosm LogoSign in Get a demo

sll

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
Has Results
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • TP-0903
    • TP-0903 and ibrutinib combination therapy
    • Phoenix, Arizona
    • +5 more
    Apr 4, 2022

    Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

    Withdrawn
    • CLL
    • +4 more
    • Treatment Free Observation
    • Basking Ridge, New Jersey
    • +8 more
    Mar 4, 2022

    Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • +8 more
    • Dose combination 1-1
    • +5 more
    • (no location specified)
    Nov 1, 2021

    CAP-100 for Relapsed/Refractory Chronic Lymphocytic Leukemia

    Recruiting
    • Lymphocytic Leukemia, Chronic
    • SLL
    • Durham, North Carolina
    • +1 more
    Sep 16, 2021

    NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

    Completed
    • NHL
    • +17 more
    • veltuzumab
    • Savannah, Georgia
    • +4 more
    Aug 12, 2021

    Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Tucson (rituximab, bortezomib, cladribine)

    Completed
    Has Results
    • Lymphoma
    • +3 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 16, 2019

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL Trial in La Jolla (A6)

    Terminated
    • Chronic Lymphocytic Leukemia
    • +3 more
    • La Jolla, California
      Moores Cancer Center, UCSD
    Jul 11, 2016